Microbial factories for recombinant pharmaceuticals N Ferrer-Miralles, J Domingo-Espín, JL Corchero, E Vázquez, ... Microbial cell factories 8, 1-8, 2009 | 613 | 2009 |
Recombinant pharmaceuticals from microbial cells: a 2015 update L Sanchez-Garcia, L Martín, R Mangues, N Ferrer-Miralles, E Vázquez, ... Microbial cell factories 15, 1-7, 2016 | 386 | 2016 |
Side effects of chaperone gene co-expression in recombinant protein production M Martínez-Alonso, E García-Fruitós, N Ferrer-Miralles, U Rinas, ... Microbial cell factories 9, 1-6, 2010 | 137 | 2010 |
Bacterial cell factories for recombinant protein production; expanding the catalogue N Ferrer-Miralles, A Villaverde Microbial cell factories 12, 1-4, 2013 | 121 | 2013 |
Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles U Unzueta, MV Céspedes, N Ferrer-Miralles, I Casanova, J Cedano, ... International journal of nanomedicine, 4533-4544, 2012 | 118 | 2012 |
Membrane-active peptides for non-viral gene therapy: making the safest easier N Ferrer-Miralles, E Vázquez, A Villaverde Trends in biotechnology 26 (5), 267-275, 2008 | 111 | 2008 |
In Vivo Architectonic Stability of Fully de Novo Designed Protein-Only Nanoparticles MV Céspedes, U Unzueta, W Tatkiewicz, A Sanchez-Chardi, ... ACS nano 8 (5), 4166-4176, 2014 | 101 | 2014 |
Bacterial inclusion bodies are industrially exploitable amyloids A De Marco, N Ferrer-Miralles, E Garcia-Fruitós, A Mitraki, S Peternel, ... FEMS microbiology reviews 43 (1), 53-72, 2019 | 97 | 2019 |
BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS H Peluffo, U Unzueta, ML Negro-Demontel, Z Xu, E Váquez, ... Biotechnology advances 33 (2), 277-287, 2015 | 95 | 2015 |
Nanostructured antimicrobial peptides: The last push towards clinics JV Carratalá, N Serna, A Villaverde, E Vázquez, N Ferrer-Miralles Biotechnology advances 44, 107603, 2020 | 91 | 2020 |
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation C Díez-Gil, S Krabbenborg, E García-Fruitós, E Vazquez, ... Biomaterials 31 (22), 5805-5812, 2010 | 82 | 2010 |
General introduction: recombinant protein production and purification of insoluble proteins N Ferrer-Miralles, P Saccardo, JL Corchero, Z Xu, E García-Fruitós Insoluble Proteins: Methods and Protocols, 1-24, 2015 | 81 | 2015 |
Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide E Vazquez, M Roldán, C Diez-Gil, U Unzueta, J Domingo-Espín, ... Nanomedicine 5 (2), 259-268, 2010 | 80 | 2010 |
A new bisintercalating anthracycline with picomolar DNA binding affinity J Portugal, DJ Cashman, JO Trent, N Ferrer-Miralles, T Przewloka, I Fokt, ... Journal of medicinal chemistry 48 (26), 8209-8219, 2005 | 78 | 2005 |
Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles U Unzueta, N Ferrer-Miralles, J Cedano, X Zikung, M Pesarrodona, ... Biomaterials 33 (33), 8714-8722, 2012 | 77 | 2012 |
Towards protein-based viral mimetics for cancer therapies U Unzueta, MV Céspedes, E Vázquez, N Ferrer-Miralles, R Mangues, ... Trends in biotechnology 33 (5), 253-258, 2015 | 75 | 2015 |
Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy N Ferrer-Miralles, E Rodríguez-Carmona, JL Corchero, E Garcia-Fruitos, ... Critical reviews in biotechnology 35 (2), 209-221, 2015 | 72 | 2015 |
Bottom-up instructive quality control in the biofabrication of smart protein materials F Rueda, MV Céspedes, O Cochinillo, A Sanchez Chardi, ... Advanced materials, 1-7, 2015 | 71 | 2015 |
Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine N Ferrer-Miralles, JL Corchero, P Kumar, JA Cedano, KC Gupta, ... Microbial cell factories 10, 1-5, 2011 | 68 | 2011 |
The N-ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene R Diaz, D Ahn, L Lopez-Barcons, M Malumbres, I Perez de Castro, J Lue, ... Cancer research 62 (15), 4514-4518, 2002 | 64 | 2002 |